Valuation Abbott Laboratories Swiss Exchange
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.00 CHF | +0.71% |
|
-2.07% | -28.28% |
Company Valuation: Abbott Laboratories
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,41,365 | 1,91,427 | 1,91,088 | 1,96,184 | 2,17,859 | 1,53,994 | - | - |
| Change | - | -20.69% | -0.18% | 2.67% | 11.05% | -29.31% | - | - |
| Enterprise Value (EV) 1 | 2,49,166 | 1,98,318 | 1,98,871 | 2,02,693 | 2,22,266 | 1,65,720 | 1,62,877 | 1,58,970 |
| Change | - | -20.41% | 0.28% | 1.92% | 9.66% | -25.44% | -1.72% | -2.4% |
| P/E | 35.7x | 28.1x | 33.8x | 14.8x | 33.7x | 22.2x | 19.1x | 16.7x |
| PBR | 6.93x | 5.2x | 4.94x | 4.11x | 4.18x | 3.12x | 2.99x | 2.78x |
| PEG | - | -36.9x | -2x | 0x | -0.7x | 3.22x | 1.2x | 1.2x |
| Capitalization / Revenue | 5.6x | 4.39x | 4.76x | 4.68x | 4.91x | 3.06x | 2.81x | 2.62x |
| EV / Revenue | 5.78x | 4.54x | 4.96x | 4.83x | 5.01x | 3.3x | 2.97x | 2.71x |
| EV / EBITDA | 19.4x | 15.9x | 19.5x | 19.1x | 18.9x | 12.4x | 11.2x | 9.98x |
| EV / EBIT | 22x | 17.7x | 22.3x | 21.8x | 21.6x | 14.2x | 12.5x | 11.1x |
| EV / FCF | 28.8x | 25.4x | 39.3x | 31.9x | 30.1x | 19.2x | 17.3x | 15.3x |
| FCF Yield | 3.47% | 3.94% | 2.54% | 3.13% | 3.33% | 5.21% | 5.79% | 6.54% |
| Dividend per Share 2 | 1.82 | 1.92 | 2.08 | 2.24 | 2.4 | 2.547 | 2.715 | 2.866 |
| Rate of return | 1.29% | 1.75% | 1.89% | 1.98% | 1.92% | 2.88% | 3.07% | 3.24% |
| EPS 2 | 3.94 | 3.91 | 3.26 | 7.64 | 3.72 | 3.976 | 4.636 | 5.291 |
| Distribution rate | 46.2% | 49.1% | 63.8% | 29.3% | 64.5% | 64% | 58.6% | 54.2% |
| Net sales 1 | 43,075 | 43,653 | 40,109 | 41,950 | 44,328 | 50,290 | 54,793 | 58,704 |
| EBITDA 1 | 12,815 | 12,485 | 10,188 | 10,635 | 11,735 | 13,388 | 14,551 | 15,928 |
| EBIT 1 | 11,324 | 11,231 | 8,911 | 9,295 | 10,301 | 11,665 | 13,038 | 14,362 |
| Net income 1 | 7,071 | 6,933 | 5,723 | 13,402 | 6,524 | 7,019 | 8,392 | 9,230 |
| Net Debt 1 | 7,801 | 6,891 | 7,783 | 6,509 | 4,407 | 11,727 | 8,883 | 4,976 |
| Reference price 2 | 140.74 | 109.79 | 110.07 | 113.11 | 125.29 | 88.41 | 88.41 | 88.41 |
| Nbr of stocks (in thousands) | 17,14,968 | 17,43,574 | 17,36,059 | 17,34,455 | 17,38,834 | 17,41,813 | - | - |
| Announcement Date | 26/01/22 | 25/01/23 | 24/01/24 | 22/01/25 | 22/01/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 19.94x | 3.45x | 12.41x | 3.6% | 10TCr | ||
| 36.04x | 8.8x | 23.02x | 1.11% | 5.93TCr | ||
| 14.32x | 0.17x | 10.77x | 0.87% | 5.29TCr | ||
| 35.88x | 2.9x | 9.94x | 2.67% | 3.97TCr | ||
| 34.4x | 1.28x | 11.29x | 0.23% | 3.04TCr | ||
| 29.61x | 5.28x | 16.83x | -.--% | 2.8TCr | ||
| 38.95x | 6.73x | 24.3x | 0.27% | 2.32TCr | ||
| 24.36x | 3.1x | 12.68x | 1.33% | 2.07TCr | ||
| 41.74x | 5.71x | 18.2x | 0.52% | 1.85TCr | ||
| Average | 30.58x | 4.16x | 15.49x | 1.18% | 4.16TCr | |
| Weighted average by Cap. | 27.78x | 4.03x | 14.87x | 1.7% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
- Valuation Abbott Laboratories
Select your edition
All financial news and data tailored to specific country editions
















